本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 远大产业控股股份有限公司(以下简称：公司) 2022 年度报告已于 2023 年 4 月 25 日发布。为便于广大投资者进一步了解公司情况，加强投资者关系管理， 增进公司与广大投资者的沟通与交流，公司定于 2023 年 5 月 18 日（星期四）在 同花顺路演平台举办 2022 年度业绩说明会，具体安排如下： 证券代码：000626 证券简称：远大控股 公告编号：2023-030 远大产业控股股份有限公司 关于举行网上业绩说明会的公告 一、说明会召开时间、地点及方式 1、时间 2023 年 5 月 18 日（星期四）下午 15:00-16:00。 2、会议召开地点: 同花顺路演平台 （https://board.10jqka.com.cn/rs/pc/detail?roadshowId=1005685）。 3、会议召开方式 网络形式。 二、公司参会人员 公司出席本次业绩说明会的人员有：董事长兼总裁史迎春先生、独立董事吴 价宝先生、副董事长兼副总裁许强先生、副总裁姜勇先生、董事会秘书代财务总 监朱丰超先生。（如有特 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥17,517,695,932.01, representing a 2.58% increase compared to ¥17,076,716,532.60 in the same period last year[6] - Net profit attributable to shareholders was ¥15,654,959.42, a significant increase of 40.41% from ¥11,149,720.14 in the previous year[6] - The company's basic earnings per share increased by 50.00% to ¥0.03, up from ¥0.02 in the same period last year[6] - In Q1 2023, the company achieved a revenue of 17.518 billion RMB, representing a year-on-year growth of 2.58%[17] - The net profit attributable to shareholders in Q1 2023 was 15.6549 million RMB, an increase of 40.41% compared to the same period last year[17] - Total operating costs for Q1 2023 were CNY 17,576,500,426.99, an increase from CNY 17,044,678,320.17 in Q1 2022, representing a growth of approximately 3.12%[35] - The company reported a total comprehensive income of CNY 13,947,843.42 for Q1 2023, compared to CNY 12,830,192.60 in Q1 2022, marking an increase of about 8.7%[36] Cash Flow and Financial Position - The net cash flow from operating activities improved to -¥801,245,598.78, a 32.75% reduction in losses compared to -¥1,191,402,355.34 in the same period last year[6] - The net cash flow from operating activities for Q1 2023 was -801,245,598.78, an improvement from -1,191,402,355.34 in Q1 2022, indicating a reduction in cash outflow[38] - The total cash inflow from operating activities was 21,381,354,028.73, compared to 18,606,675,308.77 in Q1 2022, showing growth in operational cash generation[38] - The total cash outflow from operating activities was 22,182,599,627.51, an increase from 19,798,077,664.11 in the previous year, indicating higher operational costs[38] - The cash and cash equivalents decreased to CNY 2,533,762,346.11 from CNY 2,753,973,619.75, a decline of about 7.98%[31] - The ending balance of cash and cash equivalents was 1,589,764,281.58, down from 2,249,131,730.86 in the previous year[39] Assets and Liabilities - Total assets at the end of Q1 2023 reached ¥9,689,589,496.22, marking a 24.34% increase from ¥7,792,783,558.14 at the end of the previous year[6] - The total current assets at the end of Q1 2023 amounted to CNY 7,500,128,242.38, up from CNY 6,129,987,554.72 at the beginning of the year, indicating a growth of about 22.34%[31] - The total liabilities as of March 31, 2023, were CNY 6,469,900,893.18, compared to CNY 4,515,488,519.32 at the start of the year, reflecting an increase of approximately 43.25%[32] - The company's total equity decreased slightly to CNY 3,219,688,603.04 from CNY 3,277,295,038.82, a decline of approximately 1.75%[32] Investments and Acquisitions - The company reported a significant increase in goodwill by 137.27% to ¥1,005,961,696.84 following the acquisition of Maikeluoluo Biotechnology[10] - The company has successfully completed the acquisition of Microlife Biotech, which specializes in over 50 types of biopesticides, expanding its product offerings in the agricultural sector[25] - The company’s investment income surged by 2634.94% to ¥74,773,994.00, driven by higher profits from derivative trading[10] Inventory and Borrowings - The company’s inventory increased by 124.04% to ¥2,222,055,904.07, attributed to increased stockpiling in response to commodity trading conditions[10] - The company’s short-term borrowings rose by 148.09% to ¥1,018,189,057.37, reflecting an increase in financing needs[10] Research and Development - Research and development expenses increased significantly to CNY 2,663,221.42 in Q1 2023 from CNY 210,789.67 in Q1 2022, indicating a rise of approximately 1165.4%[35] - The company has a strong focus on R&D, with over 40 patents related to biopesticides and has received multiple provincial and national awards for its innovations[23][24] Market and Customer Base - The company has established a strong customer base with over 400 upstream and downstream clients, including well-known enterprises like COFCO and Yihai Kerry[20] - The company has enhanced its agricultural promotion services, conducting over 200 promotional events nationwide, reaching over 100,000 views online[27] - The company has seen a rapid increase in the sales proportion of its formulation products, indicating a successful marketing strategy[27] Product Development - The company has introduced high-end products using Irish natural fermented cream and high-end tart crust oil, targeting the baking market[22] - The company aims to establish a mature biopesticide industrial system by 2025, focusing on R&D, production, and market promotion[26]

Financial Performance - The company's operating revenue for 2022 was ¥82,007,904,175.91, representing a 0.55% increase from ¥81,561,908,376.25 in 2021[20] - The net profit attributable to shareholders decreased by 48.41% to ¥114,594,011.79 from ¥222,141,582.30 in the previous year[20] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥174,665,916.48, a decline of 264.62% compared to ¥106,101,976.91 in 2021[20] - The net cash flow from operating activities was -¥841,937,116.50, a decrease of 209.69% from ¥767,587,134.79 in 2021[20] - Basic earnings per share fell by 46.51% to ¥0.23 from ¥0.43 in the previous year[20] - Total assets at the end of 2022 were ¥7,792,783,558.14, an increase of 2.15% from ¥7,628,880,311.03 at the end of 2021[20] - The net assets attributable to shareholders increased by 4.72% to ¥3,016,755,419.93 from ¥2,880,831,939.26 in 2021[20] - The company reported a significant uncertainty regarding its ability to continue as a going concern[20] Revenue Breakdown - The company’s revenue after deducting certain amounts was ¥82,002,871,540.99, slightly higher than ¥81,558,019,152.38 in 2021[20] - The company's total revenue for Q1 was approximately ¥17.08 billion, Q2 was ¥21.28 billion, Q3 was ¥23.31 billion, and Q4 was ¥20.35 billion, showing a significant increase in Q3 compared to Q1[24] - The net profit attributable to shareholders for Q1 was approximately ¥11.15 million, Q2 was ¥51.71 million, Q3 was ¥58.23 million, while Q4 recorded a loss of approximately ¥6.50 million[24] - The net profit attributable to shareholders after deducting non-recurring gains and losses was negative in Q2, Q3, and Q4, with figures of approximately -¥51.53 million, -¥32.82 million, and -¥95.70 million respectively[24] - Cash flow from operating activities was negative in Q1 at approximately -¥1.19 billion, improved to -¥424.60 million in Q2, positive at ¥1.67 billion in Q3, and again negative at -¥899.85 million in Q4[24] Government Support and Industry Trends - The company reported a government subsidy of approximately ¥72.55 million in 2022, an increase from ¥61.75 million in 2021 and ¥50.67 million in 2020[26] - The trading industry is transitioning from high-speed growth to high-quality development, requiring enhanced price management and resource integration capabilities[32] - The oil and fat industry is expected to grow, driven by increasing consumer demand for healthy and safe food products, with a focus on high-end edible oils[34] - The special oil industry is projected to grow significantly, with the baking food market expected to exceed ¥300 billion in 2023, indicating strong potential for growth[36] Business Operations and Strategy - The company has established a full industry chain operating model in the oil sector, focusing on palm oil and other edible oils, leveraging years of industry experience[35] - The bio-agriculture sector emphasizes high-tech and efficient agricultural production methods, aiming to improve production efficiency and achieve ecological balance[38] - The company focuses on the biological agriculture sector, with a core development direction centered on biopesticides and plant nutrition[40] - The company has established over 30 wholly-owned and holding subsidiaries, ranking 164th on the 2022 Fortune China 500 list[41] - The company holds over 40 invention patents and has participated in the formulation of 7 industry or national standards[41] - The company’s oil and fat business includes a total storage capacity of 177,000 cubic meters, making it one of the largest edible oil storage enterprises in South China[45] - The company’s subsidiary, Hongxin Foods, specializes in producing edible specialty oils and has received multiple quality management certifications[46] - The company is committed to sustainable development and has aligned its strategies with national policies on food security and environmental protection[40] Acquisitions and Investments - The company acquired 100% equity of the palm oil refining plant in Johor, Malaysia, enhancing its palm oil refining, fractionation, packaging, and sales capabilities[57] - The acquisition of the Johor facility is part of the company's strategy to strengthen its position in the palm oil industry chain and improve collaboration with upstream and downstream partners[48] - The company has implemented several acquisitions, including Hongxin Food and a palm oil refining plant in Malaysia, to strengthen its industrial foundation[64] - The company acquired 80% of Hongxin Food in April 2022, entering the specialty oils sector, which has significant growth potential and high synergy with existing palm oil and soybean oil products[67] - In October 2022, the company acquired a palm oil refining plant in Malaysia, enhancing its position in the palm oil value chain and improving its credibility and confidence in expanding downstream operations[68] Research and Development - The company has a strong research capability, utilizing accumulated data to study industry cycles and provide value-added services to clients[54] - The company has received multiple provincial and national technology awards, highlighting its commitment to innovation and quality in its products[51] - The company has launched 14 new products and optimized 63 formulas in the specialty oils business, enhancing customer engagement and market competitiveness[69] - The company has focused on risk management and optimized its organizational structure to improve operational efficiency and market competitiveness[66] - Research and development expenses surged by 323.52% to 8,254,757.68 CNY in 2022, up from 1,949,105.47 CNY in 2021, primarily due to increased investments in the bio-agriculture and oil sectors[87] Risk Management - The company has established a comprehensive risk management system based on total assets, optimizing and upgrading it to ensure effective risk control during profit generation[55] - The company has implemented a risk management system for futures and derivatives trading, focusing on compliance and risk control, with dedicated risk control teams for both spot and futures markets[128] - The company has established strategies to mitigate foreign exchange risks, utilizing appropriate hedging tools to minimize the impact of currency fluctuations on its operating performance[129] Corporate Governance - The company has maintained compliance with corporate governance regulations, ensuring that its governance structure aligns with the requirements set by regulatory authorities[134] - The company has ensured the independence of its assets, personnel, finances, institutions, and business from its controlling shareholders, maintaining operational autonomy[135] - The company has not engaged in any activities that would compromise its independence, such as sharing resources or financial accounts with its controlling shareholders[136] - The company held a total of seven temporary shareholder meetings in 2022, with investor participation rates ranging from 57.36% to 58.86%[139] - The company’s governance structure is being reviewed to ensure compliance and effectiveness following recent personnel changes[144] Employee Management - The total number of employees at the end of the reporting period is 1,039, including 50 at the parent company and 989 at major subsidiaries[164] - The employee composition includes 273 production personnel, 269 sales personnel, 44 technical personnel, 93 financial personnel, 160 administrative personnel, 45 R&D personnel, and 155 other business assistants[165] - The company emphasizes a performance and value-oriented salary policy, considering job value, performance contribution, and individual capability[166] - The employee training program includes new employee training, probation guidance, professional skills training, and management training[167] Environmental Responsibility - The company has reported no exceedances of pollutant discharge limits during the reporting period[185] - The company has committed to providing equal employment opportunities and maintaining employee rights in accordance with national labor laws[192] - The company has initiated the "Yuan Da Anxin Village" social welfare project, promoting community engagement through various activities[193] - The company has implemented clean production technologies to reduce carbon emissions and wastewater discharge during the production process[191]

[Report Statement and Important Notice](index=1&type=section&id=%E6%8A%A5%E5%91%8A%E5%A3%B0%E6%98%8E%E4%B8%8E%E9%87%8D%E8%A6%81%E6%8F%90%E7%A4%BA) This section contains the company's declaration regarding the report's accuracy and highlights that the report is unaudited [Statement](index=1&type=section&id=%E5%A3%B0%E6%98%8E) The board, supervisory board, and senior management affirm the quarterly report's truthfulness, accuracy, and completeness - Board, supervisory board, and senior management guarantee the **truthfulness, accuracy, and completeness** of the quarterly report[2](index=2&type=chunk)[3](index=3&type=chunk) - Company head, chief accountant, and accounting department head declare financial information is **true, accurate, and complete**[3](index=3&type=chunk) [Important Notice](index=1&type=section&id=%E9%87%8D%E8%A6%81%E5%86%85%E5%AE%B9%E6%8F%90%E7%A4%BA) This quarterly report has not been audited - The third-quarter report is **unaudited**[4](index=4&type=chunk) [Key Financial Data](index=2&type=section&id=%E4%B8%80%E3%80%81%E4%B8%BB%E8%A6%81%E8%B4%A2%E5%8A%A1%E6%95%B0%E6%8D%AE) This section presents the company's main accounting data and financial indicators, including revenue, net profit, and cash flow [Key Accounting Data and Financial Indicators](index=2&type=section&id=%EF%BC%88%E4%B8%80%EF%BC%89%20%E4%B8%BB%E8%A6%81%E4%BC%9A%E8%AE%A1%E6%95%B0%E6%8D%AE%E5%92%8C%E8%B4%A2%E5%8A%A1%E6%8C%87%E6%A0%87) Q3 revenue increased by **15.58%** year-on-year, but net profit attributable to shareholders decreased by **28.48%** | 指标 | 本报告期 (CNY) | 本报告期比上年同期增减 | 年初至报告期末 (CNY) | 年初至报告期末比上年同期增减 | | :--- | :--- | :--- | :--- | :--- | | 营业收入 | 23,305,561,070.12 | 15.58% | 61,661,629,248.21 | 2.63% | | 归属于上市公司股东的净利润 | 58,233,897.02 | -28.48% | 121,093,980.48 | -43.28% | | 归属于上市公司股东的扣除非经常性损益的净利润 | -32,818,412.34 | 12.31% | -78,964,905.30 | -177.44% | | 经营活动产生的现金流量净额 | — | — | 57,908,724.46 | -81.20% | | 基本每股收益（CNY/Share） | 0.12 | -25.00% | 0.24 | -41.46% | | 稀释每股收益（CNY/Share） | 0.12 | -25.00% | 0.24 | -41.46% | | 加权平均净资产收益率 | 1.96% | -0.93% | 4.11% | -3.67% | | **本报告期末** | **上年度末** | **本报告期末比上年度末增减** | | | | 总资产 | 8,986,884,260.53 | 7,628,880,311.03 | 17.80% | | | 归属于上市公司股东的所有者权益 | 3,024,294,598.51 | 2,880,831,939.26 | 4.98% | | - Net profit decline is mainly due to macro factors like the Russia-Ukraine war, global pandemic, commodity price fluctuations, logistics disruptions, and Fed interest rate hikes[5](index=5&type=chunk) - Net profit after non-recurring items is negative, primarily because futures derivative gains and fair value changes are classified as non-recurring, not affecting actual operating capability[6](index=6&type=chunk) [Non-Recurring Gains and Losses Items and Amounts](index=2&type=section&id=%EF%BC%88%E4%BA%8C%EF%BC%89%20%E9%9D%9E%E7%BB%8F%E5%B8%B8%E6%80%A7%E6%8D%9F%E7%9B%8A%E9%A1%B9%E7%9B%AE%E5%92%8C%E9%87%91%E9%A2%9D) Non-recurring gains and losses mainly comprise asset disposal losses, government subsidies, and financial asset fair value changes | 项目 | 本报告期金额 (CNY) | 年初至报告期期末金额 (CNY) | 说明 | | :--- | :--- | :--- | :--- | | 非流动资产处置损益 | -4,976,986.98 | -4,548,485.45 | 处置全资子公司BRILLIANCE RESOURCES (USA) Inc 100%股权确认的亏损额 | | 计入当期损益的政府补助 | 314,459.56 | 60,936,224.92 | 主要是全资子公司远大物产集团有限公司及其子公司收到的产业转型升级及企业扶持专项补助资金 | | 除同公司正常经营业务相关的有效套期保值业务外，持有交易性金融资产、交易性金融负债产生的公允价值变动损益，以及处置交易性金融资产、交易性金融负债和可供出售金融资产取得的投资收益 | 104,687,073.25 | 228,885,481.60 | 主要为公司为配套主营业务现货经营，合理运用期货工具和外汇合约对冲大宗商品价格及汇率波动风险，相应产生的公允价值变动损益及处置损益，该损益与主营业务经营损益密切相关 | | 除上述各项之外的其他营业外收入和支出 | 6,373,840.16 | 11,920,224.12 | | | 减：所得税影响额 | 15,062,366.40 | 67,645,203.22 | | | 少数股东权益影响额（税后） | 283,710.24 | 29,489,356.19 | | | 合计 | 91,052,309.35 | 200,058,885.78 | -- | - The company does not classify non-recurring items as recurring[10](index=10&type=chunk) [Changes and Reasons for Key Accounting Data and Financial Indicators](index=3&type=section&id=%EF%BC%88%E4%B8%89%EF%BC%89%20%E4%B8%BB%E8%A6%81%E4%BC%9A%E8%AE%A1%E6%95%B0%E6%8D%AE%E5%92%8C%E8%B4%A2%E5%8A%A1%E6%8C%87%E6%A0%87%E5%8F%91%E7%94%9F%E5%8F%98%E5%8A%A8%E7%9A%84%E6%83%85%E5%86%B5%E5%8F%8A%E5%8E%9F%E5%9B%A0) Company's financial statements show significant changes influenced by futures, M&A, R&D, exchange rates, and business strategy adjustments [Changes in Consolidated Balance Sheet Items](index=3&type=section&id=1%E3%80%81%E5%90%88%E5%B9%B6%E8%B5%84%E4%BA%A7%E8%B4%9F%E5%80%BA%E8%A1%A8%E9%A1%B9%E7%9B%AE) Balance sheet changes reflect increases in derivative financial assets, fixed assets, and contract liabilities, alongside decreases in equity investments | 报表项目 | 期末余额 (CNY) | 期初余额 (CNY) | 变动比例 (%) | 变动原因 | | :--- | :--- | :--- | :--- | | 衍生金融资产 | 70,915,250.66 | 34,309,964.51 | 106.69% | 期货合约浮动盈利增加 | | 其他权益工具投资 | - | 24,185,079.72 | -100.00% | 处置宁波远大实业投资有限公司股权 | | 固定资产 | 352,232,753.60 | 258,090,411.88 | 36.48% | 收购广东鸿信食品有限公司后固定资产价值增加 | | 在建工程 | 11,887,733.87 | 29,082,884.47 | -59.12% | 远大中心装修项目转入固定资产 | | 使用权资产 | 105,805,208.31 | 66,262,628.29 | 59.68% | 签订公司分部长期租赁合同 | | 无形资产 | 149,623,773.54 | 90,881,489.92 | 64.64% | 收购鸿信食品后无形资产价值增加 | | 开发支出 | 11,758,484.61 | 7,649,508.83 | 53.72% | 生态农业领域持续研发投入 | | 交易性金融负债 | 89,407,022.96 | 27,471,935.72 | 225.45% | 现货合约浮动亏损增加 | | 应付票据 | 1,599,220,680.00 | 865,418,000.00 | 84.79% | 采购环节扩大了票据模式的结算 | | 合同负债 | 1,060,880,076.16 | 713,922,003.87 | 48.60% | 期末签订的销售合约大于期初，预收款项增加 | | 其他应付款 | 111,245,940.33 | 73,713,132.17 | 50.92% | 鸿信食品账面应分配原股东股利 | | 长期借款 | 307,437,700.00 | 225,921,600.00 | 36.08% | 新增并购贷款 | | 租赁负债 | 92,273,213.51 | 43,627,913.75 | 111.50% | 签订公司分部长期租赁合同 | | 长期应付职工薪酬 | 85,585,964.24 | 154,295,808.33 | -44.53% | 经营业绩变化导致计提业绩奖励等减少 | | 递延所得税负债 | 17,342,915.21 | 9,996,017.79 | 73.50% | 鸿信食品账面金额合并增加 | | 其他综合收益 | -31,472,169.73 | -79,040,625.02 | 60.18% | 外币报表折算差异 | [Changes in Consolidated Income Statement Items](index=4&type=section&id=2%E3%80%81%E5%90%88%E5%B9%B6%E5%88%A9%E6%B6%A6%E8%A1%A8%E9%A1%B9%E7%9B%AE) Income statement changes show a significant increase in R&D expenses and financial expenses, while sales expenses and credit impairment losses decreased | 报表项目 | 本期发生额 (CNY) | 上期发生额 (CNY) | 变动比例 (%) | 变动原因 | | :--- | :--- | :--- | :--- | | 税金及附加 | 24,760,451.06 | 18,951,924.10 | 30.65% | 印花税较上年有所增加 | | 销售费用 | 238,773,317.29 | 357,003,835.16 | -33.12% | 经营业绩变化导致计提业绩奖励等减少 | | 研发费用 | 4,010,517.36 | 289,345.55 | 1286.06% | 生态农业领域持续研发投入 | | 财务费用 | 58,882,283.13 | 34,226,292.90 | 72.04% | 汇率波动导致汇兑损失增加 | | 公允价值变动收益 | -60,907,136.44 | -210,179,232.34 | 71.02% | 本年交易性金融资产和衍生品浮动亏损净额小于上年同期 | | 信用减值损失 | -3,529,698.27 | -12,246,416.51 | 71.18% | 坏账损失较上年同期减少 | | 营业外收入 | 12,812,552.75 | 9,230,223.08 | 38.81% | 违约金赔偿金收入较上年同期增加 | [Changes in Consolidated Cash Flow Statement Items](index=4&type=section&id=3%E3%80%81%E5%90%88%E5%B9%B6%E7%8E%B0%E9%87%91%E6%B5%81%E9%87%8F%E8%A1%A8%E9%A1%B9%E7%9B%AE) Operating, investing, and financing cash flows all significantly decreased year-on-year due to increased purchases and reduced financing | 报表项目 | 本期发生额 (CNY) | 上期发生额 (CNY) | 变动比例 (%) | 变动原因 | | :--- | :--- | :--- | :--- | | 经营活动产生的现金流量净额 | 57,908,724.46 | 307,949,261.94 | -81.20% | 商品采购支付的现金同比增加 | | 投资活动产生的现金流量净额 | 70,131,150.06 | 638,327,406.91 | -89.01% | 理财赎回收到的现金同比减少 | | 筹资活动产生的现金流量净额 | 153,649,007.26 | 360,188,841.29 | -57.34% | 融资规模同比减少 | [Shareholder Information](index=4&type=section&id=%E4%BA%8C%E3%80%81%E8%82%A1%E4%B8%9C%E4%BF%A1%E6%81%AF) This section details the total number of common shareholders and the top ten shareholders' holdings [Total Number of Common Shareholders and Top Ten Shareholders' Holdings](index=4&type=section&id=%EF%BC%88%E4%B8%80%EF%BC%89%20%E6%99%AE%E9%80%9A%E8%82%A1%E8%82%A1%E4%B8%9C%E6%80%BB%E6%95%B0%E5%92%8C%E8%A1%A8%E5%86%B3%E6%9D%83%E6%81%A2%E5%A4%8D%E7%9A%84%E4%BC%98%E5%85%88%E8%82%A1%E8%82%A1%E4%B8%9C%E6%95%B0%E9%87%8F%E5%8F%8A%E5%89%8D%E5%8D%81%E5%90%8D%E8%82%A1%E4%B8%9C%E6%8C%81%E8%82%A1%E6%83%85%E5%86%B5%E8%A1%A8) As of the reporting period, the company had **22,381** common shareholders, with China Grand Enterprises as the largest shareholder - Total number of common shareholders at the end of the reporting period was **22,381**[15](index=15&type=chunk) | 股东名称 | 股东性质 | 持股比例 | 持股数量 (Shares) | 持有有限售条件的股份数量 (Shares) | 质押、标记或冻结情况 | 数量 (Shares) | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | 中国远大集团有限责任公司 | 境内非国有法人 | 41.17% | 209,522,100 | 0 | | | | 连云港金控资本管理有限公司 | 国有法人 | 16.13% | 82,072,000 | 0 | 质押 | 40,000,000 | | 金波 | 境内自然人 | 1.26% | 6,403,681 | 5,158,786 | | | | 宁波至正投资管理有限公司 | 境内非国有法人 | 1.13% | 5,750,253 | 0 | 质押 | 5,750,253 | | 香港中央结算有限公司 | 境外法人 | 0.88% | 4,453,305 | 0 | | | | 朱培元 | 境内自然人 | 0.86% | 4,354,600 | 0 | | | | 上海毓璜投资管理有限公司－毓璜亿保丰壹號私募证券投资基金 | 其他 | 0.84% | 4,261,400 | 0 | | | | 许强 | 境内自然人 | 0.66% | 3,340,457 | 3,255,343 | 质押 | 2,253,200 | | 吴向东 | 境内自然人 | 0.61% | 3,100,000 | 0 | | | | 马敏 | 境内自然人 | 0.47% | 2,400,000 | 0 | | | - The company is unaware of any associated relationships or concerted actions among these shareholders[16](index=16&type=chunk) [Total Number of Preferred Shareholders and Top 10 Preferred Shareholders' Holdings](index=5&type=section&id=%EF%BC%88%E4%BA%8C%EF%BC%89%20%E5%85%AC%E5%8F%B8%E4%BC%98%E5%85%88%E8%82%A1%E8%82%A1%E4%B8%9C%E6%80%BB%E6%95%B0%E5%8F%8A%E5%89%8D%2010%20%E5%90%8D%E4%BC%98%E5%85%88%E8%82%A1%E8%82%A1%E4%B8%9C%E6%8C%81%E8%82%A1%E6%83%85%E5%86%B5%E8%A1%A8) The company has no preferred shareholders - The company has **no preferred shareholders**[17](index=17&type=chunk) [Other Important Matters](index=5&type=section&id=%E4%B8%89%E3%80%81%E5%85%B6%E4%BB%96%E9%87%8D%E8%A6%81%E4%BA%8B%E9%A1%B9) This section covers the company's business overview across its main segments and other significant corporate actions [Company Operations](index=5&type=section&id=%EF%BC%88%E4%B8%80%EF%BC%89%E5%85%AC%E5%8F%B8%E7%BB%8F%E8%90%A5) The company operates in trade, oils, and ecological agriculture, aiming to be a high-tech integrated trade-industry enterprise with an ESG focus - Company established in **1994**, listed in **1996**, with main businesses in trade, oils, and ecological agriculture[17](index=17&type=chunk) - Committed to becoming a large-scale high-tech integrated trade-industry enterprise, deeply integrating trade with industry and high technology, adhering to **ESG development principles**[17](index=17&type=chunk) [Trade Segment](index=6&type=section&id=%E8%B4%B8%E6%98%93%E9%A2%86%E5%9F%9F) The company maintains a leading position in bulk commodity trade and is transforming into a platform-based integrated trade service provider - The company primarily engages in energy chemicals, metals, rubber, agricultural products, and other **bulk commodity trade** and foreign trade import/export businesses[18](index=18&type=chunk) - The operating model is shifting towards a new platform-based integrated trade service provider, integrating industrial chain, warehousing logistics, price management, research sharing, and deep industry-trade integration[18](index=18&type=chunk) [Oils Segment](index=6&type=section&id=%E6%B2%B9%E8%84%82%E9%A2%86%E5%9F%9F) The company aims to build a full industrial chain operating model in oils, expanding product lines through the acquisition of FIOP in Malaysia - The company is committed to building a **full industrial chain operating model** integrating resources, R&D, scaled production, and trade[19](index=19&type=chunk) - Successfully acquired **100% equity** of FGV IFFCO Oil Products Sdn Bhd (FIOP), a Malaysian palm oil refinery, in **July 2022** to expand oil product lines and enhance industrial chain synergy[19](index=19&type=chunk) [Ecological Agriculture Segment](index=6&type=section&id=%E7%94%9F%E6%80%81%E5%86%9C%E4%B8%9A%E9%A2%86%E5%9F%9F) The company focuses on plant health, building a high-quality industrial platform through internal development and M&A, with strong emphasis on R&D and collaboration - The company focuses on **plant health**, providing green and environmentally friendly crop management solutions for professional growers[20](index=20&type=chunk) - Its subsidiary, Fujian Kaili Biological Products Co., Ltd., is the **exclusive producer of Zhongshengmycin** raw material and launched the production line for Oryzalin in **October 2022**, entering the plant growth regulator and seed treatment fields[20](index=20&type=chunk) [Other Significant Matters](index=6&type=section&id=%EF%BC%88%E4%BA%8C%EF%BC%89%E5%85%B6%E4%BB%96%E9%87%8D%E5%A4%A7%E4%BA%8B%E9%A1%B9) This section details the uncertain progress of the Shaanxi Microbe acquisition and the completion of the company's share repurchase program [Progress of Shaanxi Microbe Biotechnology Co., Ltd. Equity Acquisition](index=6&type=section&id=1%E3%80%81%E5%85%AC%E5%8F%B8%E5%85%A8%E8%B5%84%E5%AD%90%E5%85%AC%E5%8F%B8%E8%BF%9C%E5%A4%A7%E7%94%9F%E6%80%81%E7%A7%91%E6%8A%80%28%E5%AE%81%E6%B3%A2%29%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8%E4%BA%8E%202021%20%E5%B9%B4%2010%20%E6%9C%88%2029%20%E6%97%A5%E7%AD%BE%E7%BD%B2%E3%80%8A%E9%99%95%E8%A5%BF%E9%BA%A6%E5%8F%AF%E7%BD%97%E7%94%9F%E7%89%A9%E7%A7%91%E6%8A%80%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8%E8%82%A1%E6%9D%83%E8%BD%AC%E8%AE%A9%E6%A1%86%E6%9E%B6%E5%8D%8F%E8%AE%AE%E3%80%8B%EF%BC%8C%E6%8B%9F%E6%94%B6%E8%B4%AD%E9%99%95%E8%A5%BF%E9%BA%A6%E5%8F%AF%E7%BD%97%E7%94%9F%E7%89%A9%E7%A7%91%E6%8A%80%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8%2098.7%25%E8%82%A1%E6%9D%83%E3%80%82%E5%9B%A0%E6%A0%87%E7%9A%84%E5%85%AC%E5%8F%B8%E5%89%8D%E6%9C%9F%E6%9C%AA%E5%8F%8A%E6%97%B6%E3%80%81%E5%85%85%E5%88%86%E5%AE%8C%E6%88%90%E5%AE%A1%E8%AE%A1%E5%87%86%E5%A4%87%E5%B7%A5%E4%BD%9C%E4%BB%A5%E5%8F%8A%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%86%85%E6%96%B0%E5%86%A0%E8%82%BA%E7%82%8E%E7%96%AB%E6%83%85%E5%A4%9A%E7%82%B9%E7%88%86%E5%8F%91%E7%AD%89%E5%8E%9F%E5%9B%A0%EF%BC%8C%E9%A1%B9%E7%9B%AE%E6%9C%AA%E8%83%BD%E6%8C%89%E6%A1%86%E6%9E%B6%E5%8D%8F%E8%AE%A2%E7%BA%A6%E5%9C%A8%202022%20%E5%B9%B4%203%20%E6%9C%88%2015%20%E6%97%A5%E5%89%8D%E5%87%BA%E5%85%B7%E5%8D%8E%E5%AE%A1%E8%AE%A1%E3%80%81%E8%AF%84%E4%BC%B0%E6%8A%A5%E5%91%8A%E5%B9%B6%E5%BD%B1%E5%93%8D%E4%BA%86%E5%90%8E%E7%BB%AD%E5%B7%A5%E4%BD%9C%E8%BF%9B%E5%B1%95%E3%80%82%E6%88%AA%E8%87%B3%E6%9C%AC%E6%8A%A5%E5%91%8A%E6%97%A5%EF%BC%8C%E8%AF%A5%E9%A1%B9%E7%9B%AE%E5%B7%B2%E5%AE%8C%E6%88%90%E5%AE%A1%E8%AE%A1%E3%80%81%E8%AF%84%E4%BC%B0%E5%B7%A5%E4%BD%9C%EF%BC%8C%E4%BA%A4%E6%98%93%E5%90%84%E6%96%B9%E6%AD%A3%E5%9C%A8%E5%B0%B1%E7%9B%B8%E5%85%B3%E4%BA%8B%E9%A1%B9%E8%BF%9B%E8%A1%8C%E7%A0%94%E5%88%A4%E3%80%81%E6%B4%BD%E8%B0%88%EF%BC%8C%E8%83%BD%E5%90%A6%E6%9C%80%E7%BB%88%E5%AE%9E%E6%96%BD%E6%94%B6%E8%B4%AD%E5%AD%98%E5%9C%A8%E4%B8%8D%E7%A1%AE%E5%AE%9A%E6%80%A7%E3%80%82) The company's proposed acquisition of **98.7%** equity in Shaanxi Microbe Biotechnology faces uncertainty due to audit delays and pandemic impacts - The company's proposed acquisition of **98.7% equity** in Shaanxi Microbe Biotechnology Co., Ltd. faces uncertainty due to audit and valuation delays and the impact of the COVID-19 pandemic[21](index=21&type=chunk)[24](index=24&type=chunk) [Share Repurchase Completion Status](index=6&type=section&id=2%E3%80%81%E5%85%AC%E5%8F%B8%E5%88%86%E5%88%AB%E4%BA%8E%202022%20%E5%B9%B4%204%20%E6%9C%88%206%20%E6%97%A5%E3%80%814%20%E6%9C%88%2022%20%E6%97%A5%E5%8F%AC%E5%BC%80%E7%AC%AC%E5%8D%81%E5%B1%8A%E8%91%A3%E4%BA%8B%E4%BC%9A%202022%20%E5%B9%B4%E5%BA%A6%E7%AC%AC%E4%BA%94%E6%AC%A1%E4%BC%9A%E8%AE%AE%E3%80%812022%20%E5%B9%B4%E5%BA%A6%E7%AC%AC%E4%B8%89%E6%AC%A1%E4%B8%B4%E6%97%B6%E8%82%A1%E4%B8%9C%E5%A4%A7%E4%BC%9A%E5%AE%A1%E8%AE%AE%E9%80%9A%E8%BF%87%E4%BA%86%E3%80%8A%E5%85%B3%E4%BA%8E%E5%85%AC%E5%8F%B8%E5%9B%9E%E8%B4%AD%E8%82%A1%E4%BB%BD%E6%96%B9%E6%A1%88%E7%9A%84%E8%AE%AE%E6%A1%88%E3%80%8B%EF%BC%8C%E6%88%AA%E8%87%B3%202022%20%E5%B9%B4%2010%20%E6%9C%88%2021%20%E6%97%A5%EF%BC%8C%E8%82%A1%E4%BB%BD%E5%9B%9E%E8%B4%AD%E5%B7%B2%E5%AE%8C%E6%88%90%EF%BC%8C%E5%85%AC%E5%8F%B8%E9%80%9A%E8%BF%87%E5%9B%9E%E8%B4%AD%E4%B8%93%E7%94%A8%E8%AF%81%E5%88%B8%E8%B4%A6%E6%88%B7%EF%BC%8C%E4%BB%A5%E9%9B%86%E4%B8%AD%E7%AB%9E%E4%BB%B7%E6%96%B9%E5%BC%8F%E5%9B%9E%E8%B4%AD%E5%85%AC%E5%8F%B8%E8%82%A1%E4%BB%BD%202%2C313%2C600%20%E8%82%A1%EF%BC%8C%E5%8D%A0%E5%85%AC%E5%8F%B8%E6%80%BB%E8%82%A1%E6%9C%AC%E7%9A%84%200.45%25%EF%BC%8C%E6%9C%80%E9%AB%98%E6%88%90%E4%BA%A4%E4%BB%B7%E4%B8%BA%2013.57%20%E5%85%83%2F%E8%82%A1%EF%BC%8C%E6%9C%80%E4%BD%8E%E6%88%90%E4%BA%A4%E4%BB%B7%E4%B8%BA%209.36%20%E5%85%83%2F%E8%82%A1%EF%BC%8C%E6%94%AF%E4%BB%98%E7%9A%84%E6%80%BB%E9%87%91%E9%A2%9D%E4%B8%BA%2030%2C000%2C778%20%E5%85%83%EF%BC%88%E4%B8%8D%E5%90%AB%E4%BA%A4%E6%98%93%E8%B4%B9%E7%94%A8%EF%BC%89%E3%80%82%E5%9B%9E%E8%B4%AD%E8%82%A1%E4%BB%BD%E5%B7%A5%E4%BD%9C%E7%9A%84%E5%AE%9E%E6%96%BD%E7%AC%A6%E5%90%88%E7%9B%B8%E5%85%B3%E6%B3%95%E5%BE%8B%E6%B3%95%E8%A7%84%E7%9A%84%E8%A6%81%E6%B1%82%EF%BC%8C%E7%AC%A6%E5%90%88%E5%85%AC%E5%8F%B8%E6%97%A2%E5%AE%9A%E7%9A%84%E5%9B%9E%E8%B4%AD%E6%96%B9%E6%A1%88%E3%80%82) The company completed its share repurchase program on **October 21, 2022**, repurchasing **2,313,600 shares**, representing **0.45%** of total share capital - The company completed its share repurchase on **October 21, 2022**, repurchasing **2,313,600 shares**, accounting for **0.45%** of the total share capital[22](index=22&type=chunk)[24](index=24&type=chunk) - The highest transaction price for repurchased shares was **CNY 13.57/share**, the lowest was **CNY 9.36/share**, with a total payment of **CNY 30,000,778**[22](index=22&type=chunk) [Quarterly Financial Statements](index=7&type=section&id=%E5%9B%9B%E3%80%81%E5%AD%A3%E5%BA%A6%E8%B4%A2%E5%8A%A1%E6%8A%A5%E8%A1%A8) This section presents the company's consolidated balance sheet, income statement, and cash flow statement for the quarter [Consolidated Balance Sheet](index=7&type=section&id=1%E3%80%81%E5%90%88%E5%B9%B6%E8%B5%84%E4%BA%A7%E8%B4%9F%E5%80%BA%E8%A1%A8) As of **September 30, 2022**, total assets were **CNY 8,986,884,260.53**, a **17.80%** increase from the beginning of the year | 项目 | 2022年9月30日 (CNY) | 2022年1月1日 (CNY) | | :--- | :--- | :--- | | **资产** | | | | 流动资产合计 | 7,682,096,362.55 | 6,605,743,041.89 | | 非流动资产合计 | 1,304,787,897.98 | 1,023,137,269.14 | | **资产总计** | **8,986,884,260.53** | **7,628,880,311.03** | | **负债** | | | | 流动负债合计 | 5,171,871,380.29 | 4,083,794,761.74 | | 非流动负债合计 | 513,954,256.25 | 445,617,103.02 | | **负债合计** | **5,685,825,636.54** | **4,529,411,864.76** | | **所有者权益** | | | | 归属于母公司所有者权益合计 | 3,024,294,598.51 | 2,880,831,939.26 | | 少数股东权益 | 276,764,025.48 | 218,636,507.01 | | **所有者权益合计** | **3,301,058,623.99** | **3,099,468,446.27** | | **负债和所有者权益总计** | **8,986,884,260.53** | **7,628,880,311.03** | [Consolidated Income Statement from Year-Beginning to End of Reporting Period](index=9&type=section&id=2%E3%80%81%E5%90%88%E5%B9%B6%E5%B9%B4%E5%88%9D%E5%88%B0%E6%8A%A5%E5%91%8A%E6%9C%9F%E6%9C%AB%E5%88%A9%E6%B6%A6%E8%A1%A8) Year-to-date total operating revenue was **CNY 61,661,629,248.21**, with net profit attributable to parent company shareholders at **CNY 121,093,980.48** | 项目 | 本期发生额 (CNY) | 上期发生额 (CNY) | | :--- | :--- | :--- | | 营业总收入 | 61,661,629,248.21 | 60,078,565,970.03 | | 营业总成本 | 61,711,829,660.51 | 59,836,007,759.83 | | 营业利润 | 219,337,850.53 | 314,837,519.20 | | 利润总额 | 231,255,335.54 | 323,557,920.26 | | 净利润 | 159,580,091.57 | 261,956,084.21 | | 归属于母公司股东的净利润 | 121,093,980.48 | 213,511,259.22 | | 少数股东损益 | 38,486,111.09 | 48,444,824.99 | | 综合收益总额 | 218,685,312.61 | 258,286,027.37 | | 基本每股收益 | 0.24 | 0.41 | | 稀释每股收益 | 0.24 | 0.41 | [Consolidated Cash Flow Statement from Year-Beginning to End of Reporting Period](index=11&type=section&id=3%E3%80%81%E5%90%88%E5%B9%B6%E5%B9%B4%E5%88%9D%E5%88%B0%E6%8A%A5%E5%91%8A%E6%9C%9F%E6%9C%AB%E7%8E%B0%E9%87%91%E6%B5%81%E9%87%8F%E8%A1%A8) From year-beginning to the end of the reporting period, operating, investing, and financing cash flows all saw significant year-on-year decreases | 项目 | 本期发生额 (CNY) | 上期发生额 (CNY) | | :--- | :--- | :--- | | 经营活动产生的现金流量净额 | 57,908,724.46 | 307,949,261.94 | | 投资活动产生的现金流量净额 | 70,131,150.06 | 638,327,406.91 | | 筹资活动产生的现金流量净额 | 153,649,007.26 | 360,188,841.29 | | 汇率变动对现金及现金等价物的影响 | 123,935,041.02 | -1,393,107.25 | | 现金及现金等价物净增加额 | 405,623,922.80 | 1,305,072,402.89 | | 期末现金及现金等价物余额 | 2,844,191,248.56 | 2,409,527,305.21 | [Audit Report](index=12&type=section&id=%EF%BC%88%E4%BA%8C%EF%BC%89%20%E5%AE%A1%E8%AE%A1%E6%8A%A5%E5%91%8A) This section confirms that the company's **2022** third-quarter report is unaudited [Audit Report](index=12&type=section&id=%E5%AE%A1%E8%AE%A1%E6%8A%A5%E5%91%8A) The company's **2022** third-quarter report is unaudited - The company's third-quarter report is **unaudited**[35](index=35&type=chunk)

Financial Performance - The company's operating revenue for the first half of 2022 was ¥38.36 billion, a decrease of 3.90% compared to ¥39.91 billion in the same period last year[22]. - The net profit attributable to shareholders was ¥62.86 million, down 52.41% from ¥132.09 million year-on-year[22]. - The net profit after deducting non-recurring gains and losses was -¥46.15 million, a decline of 135.17% compared to ¥131.20 million in the previous year[22]. - The net cash flow from operating activities was -¥1.62 billion, a decrease of 442.93% from ¥471.23 million in the same period last year[22]. - The company's basic and diluted earnings per share were both ¥0.12, a decrease of 52.00% from ¥0.25 in the same period last year[22]. - The weighted average return on net assets was 2.15%, down 2.74% from 4.89% in the previous year[22]. - The total revenue for the reporting period was ¥38,356,068,178.09, a decrease of 3.90% compared to ¥39,914,455,589.17 in the same period last year[51]. - The cost of goods sold was ¥38,082,876,704.66, down 3.01% from ¥39,266,005,722.83 year-over-year[51]. - The net profit for the same period was CNY 69.376 million, representing a significant decline of 67.67% year-on-year[79]. - The total comprehensive income for the first half of 2022 was CNY 98.14 million, compared to CNY 162.68 million in the same period of 2021, reflecting a decline of approximately 39.5%[163]. Assets and Liabilities - The total assets at the end of the reporting period were ¥8.46 billion, an increase of 10.85% from ¥7.63 billion at the end of the previous year[22]. - The net assets attributable to shareholders at the end of the reporting period were ¥2.94 billion, up 1.96% from ¥2.88 billion at the end of the previous year[22]. - The company's total assets increased to CNY 8.46 billion as of June 30, 2022, compared to CNY 7.63 billion at the beginning of the year, reflecting a growth of 10.8%[155]. - Total liabilities rose to CNY 5.25 billion, up from CNY 4.53 billion at the start of the year, marking an increase of 15.9%[155]. - The company's equity attributable to shareholders reached CNY 2.94 billion, compared to CNY 2.88 billion at the beginning of the year, representing a growth of 2.9%[155]. Cash Flow - The company's cash and cash equivalents decreased by 157.73% to -¥634,909,368.89, primarily due to the negative cash flow from operating activities[51]. - The net cash flow from operating activities was negative at -¥1,616,001,881.29, a decline of 442.93% compared to ¥471,232,899.04 in the previous year[51]. - The net cash flow from investment activities was 350,780,371.41 CNY, a decrease of 26.1% compared to 474,889,049.70 CNY in the previous period[169]. - The net cash flow from financing activities increased significantly to 575,454,940.14 CNY, compared to 151,468,636.76 CNY in the same period last year, marking an increase of 279.5%[169]. - The cash flow from operating activities was primarily driven by an increase in cash received from other operating activities, which rose to 847,083,182.82 CNY from 566,486,226.33 CNY, an increase of 49.5%[170]. Business Strategy and Operations - The company is focusing on the integration of trade, oil, and ecological agriculture, aiming for a high-tech enterprise transformation[34]. - The company has established over 30 subsidiaries and has set up business institutions in multiple countries and regions[32]. - The company is enhancing its oil and fat business by expanding its upstream resource acquisition and improving processing capabilities[39]. - The company aims to build a global vertical industry chain integrating raw materials, storage, refining, and end products, striving to become a leader in the oil industry[43]. - The company is focusing on ecological agriculture, providing green crop management solutions to professional growers, and emphasizing research and innovation[44]. Research and Development - The company has rapidly built a biological pesticide production system and is developing a range of innovative biological pesticide products[45]. - The company plans to enhance its ecological agriculture product offerings through collaborations with research institutions and continuous innovation[47]. - New product development initiatives are underway, with an investment of 12,870 million allocated for R&D in 2022, compared to 6,000 million in 2021, marking a 114.5% increase[122]. - Research and development expenses for the first half of 2022 were CNY 1.92 million, with no prior year data available for comparison[162]. Risk Management - The company emphasizes risk management and has implemented measures to mitigate foreign exchange risks[36]. - The company has established strict risk management processes for derivative investments, including stop-loss mechanisms and compliance with legal regulations[78]. - The company faced market risks associated with price fluctuations in derivative trading, which could lead to trading losses[73]. - Liquidity risks were identified due to potential large investment amounts in futures trading, which could result in forced liquidation if margin calls are not met[73]. - Credit risks were highlighted, particularly from potential defaults by clients during commodity price fluctuations[73]. Environmental Compliance - Yuan Da Oil (Dongguan) reported a wastewater discharge of 3.237 tons/year, with a COD concentration of 55.51 mg/L, which is below the standard limit of 90 mg/L[91]. - The company operates a wastewater treatment facility with a capacity of 360 tons/day, which is functioning normally[92]. - The company has a VOCs emission of 3.36 tons/year, with a concentration of 15.4 mg/m³, compliant with the emission standard[91]. - Both companies maintain a commitment to environmental protection and compliance with local regulations, ensuring sustainable operations[94]. - The company has not faced any administrative penalties due to environmental issues during the reporting period[96]. Shareholder and Equity Information - The company reported a total of 209,522,100 shares held by its largest shareholder, China Yuanda Group, representing 41.17% of total shares[139]. - The second-largest shareholder, Lianyungang Jinkong Capital Management Co., Ltd., holds 82,072,000 shares, accounting for 16.13%[139]. - The company has not undergone any changes in its controlling shareholder during the reporting period[142]. - The company does not plan to distribute cash dividends or issue bonus shares for the half-year period[87]. - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties during the reporting period[101]. Future Outlook - Future guidance estimates a revenue growth of 20% for the full year 2022, aiming for a total of 1.2 billion yuan[175]. - The company plans to enhance production process upgrades and product innovation to capture market opportunities amid increasing competition[81]. - The company is considering potential acquisitions to bolster its market position, with a budget of 13,475 million earmarked for strategic acquisitions in 2022[122]. - The company aims to enhance its technological capabilities, focusing on sustainable energy solutions, with a projected budget of 5,000 million for technology upgrades in 2022[122].

Financial Performance - The company's operating revenue for Q1 2022 was ¥17,076,716,532.60, a decrease of 4.44% compared to ¥17,870,174,057.49 in the same period last year[3] - Net profit attributable to shareholders was ¥11,149,720.14, down 81.15% from ¥59,136,325.01 year-on-year[3] - Basic and diluted earnings per share were both ¥0.02, down 83.33% from ¥0.12 in the same period last year[3] - Net profit for the current period is ¥21,081,266.64, a decline of 75.32% compared to ¥85,520,902.55 in the previous period[26] - The total profit for the current period is ¥42,377,029.34, a decrease of 59.93% from ¥105,741,516.00 in the previous period[26] - Other comprehensive income after tax for the current period is -¥8,251,074.04, contrasting with a gain of ¥180,619.84 in the previous period[26] Cash Flow - The net cash flow from operating activities was -¥1,191,402,355.34, representing a decline of 446.84% compared to -¥217,869,955.55 in the previous year[3] - The company reported a net cash outflow from operating activities of ¥1,191,402,355.34, compared to an outflow of ¥217,869,955.55 in the previous period[28] - The net cash flow from investing activities surged by 393.90% to ¥606,518,752.47, primarily due to cash received from redeeming financial products[8] - The company achieved an investment activity net cash inflow of ¥606,518,752.47, compared to ¥122,802,991.70 in the previous period[29] Assets and Liabilities - Total assets increased by 11.31% to ¥8,491,495,668.20 from ¥7,628,880,311.03 at the end of the previous year[3] - The company's total liabilities increased to CNY 5,379,197,029.33 from CNY 4,529,411,864.76, representing a rise of about 18.7%[23] - Cash and cash equivalents decreased to CNY 3,015,439,025.36 from CNY 3,132,935,277.32, a decline of about 3.8%[21] - Total current assets reached CNY 7,463,608,184.35, up from CNY 6,605,743,041.89, showing an increase of approximately 13.0%[22] Shareholder Information - The total number of common shareholders at the end of the reporting period is 17,794[10] - China Yuanda Group holds 41.17% of shares, totaling 209,522,100 shares[10] - The company repurchased shares as part of its strategy to enhance shareholder value, with announcements made on April 7, 2022[19] Business Strategy and Expansion - The company has over 30 subsidiaries and is expanding its business in multiple countries and regions[12] - The company has established strategic partnerships with several Fortune 500 companies in the bulk commodity trading sector[13] - In April 2022, the company acquired 80% of Guangdong Hongxin Food Co., Ltd., entering the specialty oil sector[14] - The company is transitioning its business model from single trade profit to integrated supply chain services[13] - The company aims to contribute to national food security and green development through its operations[12] - The acquisition of Shaanxi Maikelo Biotechnology Co., Ltd. is currently under audit and evaluation, with uncertainty regarding its implementation[16] Operational Metrics - The company experienced a 50.30% reduction in selling expenses, totaling ¥54,922,876.93, attributed to lower employee compensation[8] - The weighted average return on equity decreased to 0.39% from 2.22% in the previous year[3] - The company reported a significant increase in accounts receivable, which rose by 101.79% to ¥1,226,554,136.84 due to higher shipment volumes[7] - Inventory levels increased by 58.99% to ¥1,355,174,429.56, driven by expectations of rising product prices[7] - Short-term borrowings surged to CNY 811,956,391.57 from CNY 390,671,110.81, an increase of approximately 108.5%[22]

Financial Performance - The company's operating revenue for 2021 was ¥81,561,908,376.25, representing a 38.14% increase compared to ¥59,041,455,357.74 in 2020[18]. - The net profit attributable to shareholders for 2021 was ¥222,141,582.30, a significant turnaround from a loss of ¥113,193,841.51 in 2020, marking a 296.25% increase[18]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥106,101,976.91, up 129.60% from ¥46,212,410.38 in 2020[18]. - The net cash flow from operating activities was ¥767,587,134.79, a 325.56% increase from a negative cash flow of ¥340,301,495.45 in 2020[18]. - The basic earnings per share for 2021 was ¥0.43, compared to a loss of ¥0.21 per share in 2020, reflecting a 304.76% improvement[18]. - The total assets at the end of 2021 were ¥7,628,880,311.03, a 15.34% increase from ¥6,614,086,516.44 at the end of 2020[18]. - The net assets attributable to shareholders at the end of 2021 were ¥2,880,831,939.26, up 9.12% from ¥2,640,159,069.96 at the end of 2020[18]. - The weighted average return on equity for 2021 was 8.05%, a recovery from -4.17% in 2020, indicating a 12.22% improvement[18]. Revenue Breakdown - The company's total revenue for Q1, Q2, Q3, and Q4 was approximately ¥17.87 billion, ¥22.04 billion, ¥20.16 billion, and ¥21.48 billion respectively, showing a strong performance in Q2[22]. - The revenue from commodity trading accounted for 99.82% of total operating revenue, amounting to ¥81.41 billion, which is a 38.14% increase from the previous year[60]. - Domestic sales contributed ¥70.70 billion, accounting for 86.68% of total revenue, with a year-on-year growth of 38.48%[60]. Strategic Initiatives - The company aims to integrate vertically across the palm oil supply chain, enhancing its competitive edge in the market[32]. - The company is focusing on the high-end edible oil market, which is expected to grow due to rising consumer health awareness and income levels[31]. - The company has established over 30 subsidiaries and is actively expanding its business in multiple countries and regions, emphasizing the integration of trade and high-tech agriculture[36]. - The company plans to acquire Guangdong Hongxin to enter the specialty oils market, further deepening its full industry chain layout[38]. - The company has initiated the industrialization process of ecological agriculture, collaborating with the Chinese Academy of Agricultural Sciences to establish a research and development center[40]. Environmental and Social Responsibility - The company is committed to environmental, social, and governance performance, aligning its operations with national goals for carbon neutrality and ecological protection[36]. - The company aims to achieve zero emissions in industrial wastewater and waste during the production of its biological pesticides, aligning with environmental sustainability goals[45]. - The company emphasizes social responsibility, providing equal employment opportunities and adhering to labor laws[170]. - The company continues to promote the "Yuan Da Anxin Village" social welfare project, donating educational materials to schools in need[170]. Risk Management - The company has developed a comprehensive risk management system to ensure effective control of risks while pursuing profit[42]. - The company has identified several key risks, including market risk and liquidity risk, which it is actively managing[92]. - The company has established a risk management system to monitor market risks associated with its hedging business model, ensuring effective execution of its strategies[110]. - The company is implementing strategies to mitigate foreign exchange risks, utilizing appropriate hedging tools to minimize the impact of currency fluctuations on its operating performance[111]. Corporate Governance - The company adheres to regulatory requirements for corporate governance, ensuring compliance with laws and maintaining the interests of all shareholders[114]. - The company maintains independence from its controlling shareholders in terms of assets, personnel, finance, and operations, ensuring no conflicts of interest[116]. - The company is committed to a production and operational model that is independent from its controlling shareholders, ensuring no competitive conflicts arise[119]. - The board of directors has been proactive in addressing potential risks related to goodwill impairment and management team integration during acquisitions[144]. Subsidiary Developments - The company acquired 100% equity of Liaoning Weike Biological Engineering Co., Ltd. and 85.1166% equity of Fujian Kaili Biological Products Co., Ltd. in 2021[138]. - The newly established subsidiary, Yuan Da Energy Chemical (Singapore) Co., Ltd., reported revenue of CNY 82,755,503.12 but incurred a net loss of CNY 6,128,397.30 during the reporting period[190]. - The company also established Yuan Da Rubber (Singapore) Co., Ltd., which generated revenue of CNY 522,644,021.01 with a net loss of CNY 898,312.71[190]. Future Outlook - The company plans to expand its market presence, focusing on new product development and technological advancements[92]. - The company aims to transition from a B2B model to a B2C model by developing small packaged palm oil products and exploring high-value specialty oils[107]. - The company is likely to pursue further strategic initiatives, including potential mergers and acquisitions, to bolster its market position[128].

Financial Performance - The company's operating revenue for Q3 2021 was ¥20,164,110,380.86, representing a 22.58% increase year-over-year[3]. - Net profit attributable to shareholders for the same period was ¥81,421,377.39, a significant increase of 73.93% compared to the previous year[3]. - The basic earnings per share for Q3 2021 was ¥0.16, reflecting an 85.61% increase year-over-year[3]. - In the first three quarters of 2021, the company achieved operating revenue of CNY 60.08 billion, an increase of 50.84% compared to the same period last year[13]. - The net profit attributable to shareholders of the listed company was CNY 2.14 billion, turning from a loss of CNY 0.52 billion in the same period last year, representing a growth of 508.64%[13]. - Total operating revenue for the current period reached ¥60,078,565,970.03, a significant increase of 50.8% compared to ¥39,828,721,919.73 in the previous period[25]. - Net profit for the current period was ¥261,956,084.21, a turnaround from a net loss of ¥482,786.39 in the previous period[26]. - The profit attributable to the parent company's shareholders was ¥213,511,259.22, compared to a loss of ¥52,248,872.42 in the same period last year[26]. - Earnings per share (basic and diluted) improved to ¥0.41 from a loss of ¥0.10 in the previous period[27]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥8,521,954,349.32, marking a 28.85% increase from the end of the previous year[3]. - The total assets of the company as of September 30, 2021, were CNY 85.22 billion, an increase of 28.85% from the end of the previous year[13]. - The company’s total current assets increased to approximately CNY 7.53 billion as of September 30, 2021, compared to CNY 6.07 billion at the end of 2020, reflecting a growth of about 24.1%[21]. - The company’s total liabilities increased to approximately CNY 4.98 billion as of September 30, 2021, compared to CNY 3.65 billion at the end of 2020, indicating a growth of about 36.5%[22]. - Total liabilities increased to ¥5,385,132,008.05 from ¥3,796,158,878.80, indicating a growth of 42%[26]. - Total liabilities amounted to CNY 3,796,158,878.80, with current liabilities at CNY 3,647,163,716.33[35]. - Non-current liabilities totaled CNY 148,995,162.47, including lease liabilities of CNY 80,999,995.79[35]. Cash Flow - The company reported a cash flow from operating activities of ¥307,949,261.94, which is a 167.68% increase year-to-date[3]. - The company reported a cash flow from operating activities of CNY 307.95 million, a turnaround from a negative cash flow of CNY 455.02 million in the same period last year, representing a growth of 167.68%[12]. - Cash generated from operating activities was ¥66,108,607,914.03, an increase from ¥44,767,061,249.95 in the prior period[29]. - The net cash flow from operating activities was CNY 307,949,261.94, a significant improvement compared to a negative cash flow of CNY -455,019,204.43 in the same period last year[30]. - The total cash inflow from investment activities reached CNY 8,663,411,829.92, up from CNY 6,026,619,609.68 year-over-year[30]. - The net cash flow from financing activities was CNY 360,188,841.29, compared to CNY 129,678,510.36 in the previous year, indicating a positive trend in financing[31]. - The total cash and cash equivalents at the end of the period amounted to CNY 2,409,527,305.21, an increase from CNY 1,880,779,075.19 at the end of the previous year[31]. - The company reported a total investment cash outflow of CNY 8,025,084,423.01, compared to CNY 5,532,926,608.29 in the previous year, indicating increased investment activity[30]. Equity - The company’s total equity attributable to shareholders increased by 9.91% to ¥2,901,900,767.26 compared to the end of the previous year[3]. - The company's equity attributable to shareholders of the listed company was CNY 29.02 billion, up 9.91% from the end of the previous year[13]. - Total equity reached CNY 2,817,927,637.64, with equity attributable to shareholders of the parent company at CNY 2,640,159,069.96[35]. - The company reported an unallocated profit of CNY 837,293,855.00 within its equity structure[35]. Investments and Acquisitions - Fixed assets increased by 135.51% to ¥265,250,401.29, primarily due to the acquisition of Fujian Kaili Biological Products Co., Ltd.[8]. - The company acquired an 85.1166% stake in Fujian Kaili, a high-tech enterprise engaged in the R&D, production, and sales of biopesticide raw materials and formulations, which holds a patent for Zhongshengmycin raw materials[15]. - The company plans to integrate and acquire in the ecological agriculture sector, focusing on product research and application technology innovation[14]. - The company aims to enhance its oil and fat industry chain by establishing long-term partnerships with local enterprises through overseas asset acquisitions and joint ventures, focusing on stable and traceable oil material supply[16]. Strategic Initiatives - The company aims to combine trade with high technology, striving to become a large integrated enterprise in trade and industry[14]. - The company has established strategic partnerships with several Fortune 500 companies, maintaining a leading position in the bulk commodity trading sector[14]. - The company emphasizes the innovation and product layout in biopesticide research and development, collaborating with the Chinese Academy of Agricultural Sciences to establish an ecological agriculture R&D center[15]. Other Information - The company’s subsidiary, Yuanda Oil (Dongguan) Co., Ltd., was approved to become a designated delivery warehouse for palm oil at the Dalian Commodity Exchange[16]. - The company received approval from the China Securities Regulatory Commission for a non-public issuance of A-shares, indicating ongoing capital-raising efforts[17]. - The report for the third quarter of 2021 was not audited[36].

Financial Performance - The company's operating revenue for the reporting period reached ¥39.91 billion, representing a 70.73% increase compared to ¥23.38 billion in the same period last year[19]. - Net profit attributable to shareholders was ¥132.09 million, a significant turnaround from a loss of ¥99.06 million in the previous year, marking a 233.34% increase[19]. - The net profit after deducting non-recurring gains and losses was ¥131.20 million, compared to a loss of ¥35.99 million last year, reflecting a 464.58% improvement[19]. - The net cash flow from operating activities was ¥471.23 million, a 451.23% increase from a negative cash flow of ¥134.17 million in the same period last year[19]. - Basic earnings per share increased to ¥0.25 from a loss of ¥0.18, representing a 238.89% improvement[19]. - Total assets at the end of the reporting period were ¥8.60 billion, up 29.98% from ¥6.61 billion at the end of the previous year[19]. - Net assets attributable to shareholders increased to ¥2.78 billion, a 5.14% rise from ¥2.64 billion at the end of the previous year[19]. Business Strategy and Operations - The company plans to focus on high-tech agricultural development while expanding its commodity trading business, aiming to integrate trade with industry and high technology[27]. - The company operates in three main sectors: trade, ecological agriculture, and oil, with over 30 subsidiaries and business institutions established in multiple countries[27]. - The company maintained a leading position in the bulk commodity trade sector, establishing strategic partnerships with multiple Fortune 500 companies[29]. - The export scale of foreign trade business increased year-on-year, with stable profit margins despite challenges such as international shipping difficulties and exchange rate fluctuations[29]. - The company established a research and development center in collaboration with the Chinese Academy of Agricultural Sciences to innovate in biopesticide development[30]. - The company acquired an 85.12% stake in Fujian Kaili Biological Products Co., which specializes in biopesticide research and production[30]. - The company is conducting due diligence for a proposed acquisition of 100% of Liaoning Weike Biological Engineering Co., which focuses on biopesticides and biofertilizers[30]. - The company aims to enhance its oilseed supply chain through overseas asset acquisitions and joint ventures, improving resource quality and traceability[31]. Revenue and Sales - Revenue from commodity trading was ¥39,889,528,812.52, accounting for 99.94% of total revenue, with a year-on-year growth of 70.92%[36]. - Domestic sales amounted to ¥33,947,647,582.44, making up 85.05% of total revenue, reflecting a 70.22% increase from the previous year[36]. - Revenue from liquefied products trading was ¥19,349,234,320.84, which is 48.48% of total revenue, showing a 71.27% increase year-on-year[36]. - Metal products trading revenue surged to ¥9,897,670,245.33, a remarkable increase of 148.20% compared to the previous year[36]. - The gross profit margin for commodity trading improved by 0.48% year-on-year, reaching 1.62%[37]. Cash Flow and Investments - Cash flow from operating activities increased by 451.23% to CNY 471.23 million, primarily due to increased sales revenue[34]. - The company's cash and cash equivalents increased to ¥3,415,439,835.53, representing 39.73% of total assets, up from 27.49% the previous year[42]. - The company reported a total of ¥1,325,332,541.66 in receivables financing during the reporting period[47]. - The company has made significant equity investments, including a 85.12% stake in Fujian Kaili Biological Products Co., Ltd. for ¥478,940,000.00[50]. - The total amount of derivative investments was ¥783,519,000.34, with a net investment amount of ¥829,711,000.00 at the end of the reporting period[55]. Risk Management - The company faces macroeconomic volatility risks, with recent uncertainties impacting commodity prices and operational pressures[65]. - The market risk associated with hedging strategies may lead to significant losses if market conditions change drastically, highlighting the importance of effective risk management[66]. - The company has established risk control teams to monitor both spot and futures markets, ensuring effective execution of its hedging strategies[66]. - Cash liquidity risks may arise from margin requirements in futures trading, potentially leading to forced liquidation if cash reserves are insufficient[66]. - The company has implemented measures to mitigate contract performance risks by conducting thorough credit assessments of suppliers and customers[67]. Shareholder and Equity Management - The company does not plan to distribute cash dividends or issue bonus shares for the reporting period[6]. - The company has not sold any significant assets or equity during the reporting period, indicating stability in its asset management[58][59]. - The company reported a total cash dividend of approximately CNY 18.21 million distributed prior to the cancellation of 55,759,636 shares[95]. - The second compensation plan involves the repurchase and cancellation of 33,934,438 shares, with a total cash dividend of CNY 11.08 million to be returned[96]. - The largest shareholder, China Yuanda Group Co., Ltd., holds 41.17% of the total shares, amounting to 209,522,100 shares[123]. Environmental and Social Responsibility - The company has a wastewater treatment capacity of 360 tons per day and operates normally[76]. - The company has a deodorization tower with a capacity of 1200 tons per day, also operating normally[76]. - The total wastewater discharge is 0.21557 tons, while the approved discharge limit is 3.237 tons per year, indicating no exceedance[76]. - The company received no administrative penalties for environmental issues during the reporting period[77]. - The company continues to promote the "Yuan Da Anxin Village" social welfare project, donating educational materials to schools[79]. Financial Reporting and Compliance - The financial report for the half-year period was not audited[86]. - The company’s financial statements were approved by the board of directors on August 9, 2021, ensuring compliance with accounting standards[173]. - The company adheres to the enterprise accounting standards, ensuring that financial statements accurately reflect its financial position, operating results, and cash flows[176]. - The accounting period is defined as January 1 to December 31 each year[177]. Future Outlook - The company has plans to focus on new product development and market expansion to drive future revenue growth[164]. - The overall financial health of the company suggests potential opportunities for mergers and acquisitions to strengthen market position[164].

Financial Performance - The company's operating revenue for Q1 2021 was ¥17,870,174,057.49, representing an increase of 81.80% compared to the same period last year[8]. - The net profit attributable to shareholders was ¥59,136,325.01, a significant turnaround from a loss of ¥163,659,414.65 in the previous year, marking a 136.13% improvement[8]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥103,662,253.19, compared to a loss of ¥110,663,626.09 last year, reflecting a 193.67% increase[8]. - The basic earnings per share increased to ¥0.12 from a loss of ¥0.30, representing a 140.00% improvement[8]. - The company achieved operating revenue of 17.87 billion yuan, representing a year-on-year growth of 81.80%[33]. - The net profit attributable to shareholders was 59.14 million yuan, an increase of 136.13% year-on-year[33]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was 103.66 million yuan, up 193.67% year-on-year[33]. - The company reported a total comprehensive income for Q1 2021 of ¥85,701,522.39, compared to a loss of ¥121,448,376.34 in the previous year[51]. Assets and Liabilities - The total assets at the end of the reporting period were ¥8,108,169,351.87, up 22.59% from the end of the previous year[8]. - The net assets attributable to shareholders increased to ¥2,710,380,114.05, a rise of 2.66% compared to the previous year[8]. - Total liabilities reached ¥5,193,492,612.45, compared to ¥3,796,158,878.80, indicating an increase of around 37%[42]. - The company's total assets amounted to ¥8,108,169,351.87, up from ¥6,614,086,516.44, which is an increase of about 22.5%[43]. - Short-term borrowings surged to ¥952,415,296.48 from ¥327,130,623.79, representing an increase of approximately 191.5%[41]. - The company's total liabilities increased significantly, with accounts payable rising by 36.79% to ¥1,857,796,262.45 due to increased procurement volumes[16]. Cash Flow - The net cash flow from operating activities was negative at -¥217,869,955.55, worsening by 102.32% compared to -¥107,685,253.38 in the same period last year[8]. - The company reported a net cash outflow from operating activities of ¥-217,869,955.55, which is a 102.32% increase in outflow compared to the previous year[17]. - Cash inflows from operating activities amounted to CNY 19.97 billion, up from CNY 11.47 billion in the previous period, representing a growth of approximately 74%[57]. - The net cash flow from investing activities was positive CNY 122.80 million, down from CNY 293.41 million in the previous year[58]. - The net cash flow from financing activities was CNY 527.87 million, compared to CNY 289.19 million in the same period last year, reflecting a growth of approximately 83%[59]. Investments and Subsidiaries - The company signed agreements to acquire 85.12% of Fujian Kaili Biological Products Co., Ltd. and 100% of Liaoning Weike Biological Engineering Co., Ltd.[34]. - The company completed the first phase of performance compensation related to a major asset restructuring, involving the repurchase of 55,759,636 shares[18]. - The second phase of performance compensation was approved, involving the repurchase of 33,934,438 shares, following a judicial ruling on a related case[19]. - The bankruptcy proceedings for the subsidiary, Far East Petrochemical Co., Ltd., are ongoing after it filed for bankruptcy in November 2020[20]. - The company’s subsidiary, Yuanda Petrochemical Co., Ltd., applied for bankruptcy liquidation, indicating potential financial distress within the group[22]. Risk Management - The company has established strict risk management measures for derivative investments, including a stop-loss mechanism to limit losses beyond a certain threshold[26]. - The company’s derivative trading activities are subject to market risks, liquidity risks, credit risks, operational risks, policy risks, and legal risks[26]. - The company’s risk control measures include selecting reputable futures brokerage firms and establishing a comprehensive management process for derivative investments[26]. Research and Development - The company plans to invest 10 million yuan to establish a research and development center in collaboration with the Chinese Academy of Agricultural Sciences[34]. - The first phase of the R&D center will have an incubation fund of 50 million yuan provided by the company or its affiliated agricultural high-tech enterprises[36]. - The company emphasizes innovation in biological pesticide research and development, leveraging partnerships with leading research institutions[36]. - The company aims to continue increasing investments in the agricultural high-tech sector to drive innovation and industrialization[36].